Skip to content
Screener

Total Current Assets at other companies

GPA
General Purpose Acquisition Corp.GPAC
$1.71M-29.8%
Veradermics logo
VeradermicsMANE
$397.07M
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$3.5M
Schering-Plough logo
Schering-PloughSGP
$253.36M
Dycom Industries logo
Dycom IndustriesDY
$2.97B+62.8%
Target logo
TargetTGT
$18.07B+1.7%

Where this comes from

Reported directly by First Tracks Biotherapeutics Inc in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224190
Line itemMarch 31, 2026December 31,2025
Cash and cash equivalents$248,469$238,196
Short-term investments37,98673,442
Prepaid expenses and other current assets2,9474,762
Total current assets289,402316,400
Property and equipment, net1,1741,370
Operating lease right-of-use assets12,519
Other long-term assets256
Total assets$290,576$330,545

Item 1. Combined Financial Statements.

FAQ

What is First Tracks Biotherapeutics Inc's total current assets?
First Tracks Biotherapeutics Inc (TRAX) reported total current assets of $289.4M in Q1 2026.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about First Tracks Biotherapeutics Inc's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude